Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells-Reference-Cited by-同舟云学术

Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells

Published:2014-12-18 Issue:5 Volume:6 Page:2779-2793
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Loria Rossella¹,Bon Giulia¹,Perotti Valentina²,Gallo Enzo³,Bersani Ilaria²,Baldassari Paola²,Porru Manuela⁴,Leonetti Carlo⁴,Di Carlo Selene¹,Visca Paolo³,Brizzi Maria Felice⁵,Anichini Andrea²,Mortarini Roberta²,Falcioni Rita¹

Affiliation:

1. Department of Experimental Oncology, Regina Elena National Cancer Institute, Rome, Italy

2. Human Tumors Immunobiology Unit, Dept. of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

3. Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy

4. Department of Chemotherapy, Regina Elena National Cancer Institute, Rome, Italy

5. Department of Medical Sciences, University of Turin, Turin, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical and structural insights into the auto-inhibited state of Mical1 and its activation by Rab8;2024-06-17

2. PlexinA1 promotes gastric cancer migration through preventing MICAL1 protein ubiquitin/proteasome-mediated degradation in a Rac1-dependent manner;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-04

3. CircSEMA6A upregulates PRRG4 by targeting MiR-520h and recruiting ELAVL1 to affect cell invasion and migration in papillary thyroid carcinoma;Archives of Endocrinology and Metabolism;2024

4. Comprehensive analysis of necroptotic patterns and associated immune landscapes in individualized treatment of skin cutaneous melanoma;Scientific Reports;2023-11-30

5. Advancing diabetes prediction with a progressive self-transfer learning framework for discrete time series data;Scientific Reports;2023-11-29